| scholarly article | Q13442814 |
| P2093 | author name string | Igor A Parshikov | |
| John B Sutherland | |||
| P2860 | cites work | DNA gyrase, topoisomerase IV, and the 4-quinolones | Q24643546 |
| In vitro and in vivo activities of atalaphillinine and related acridone alkaloids against rodent malaria | Q24679630 | ||
| In vitro activities of furoquinoline and acridone alkaloids against Plasmodium falciparum | Q24679711 | ||
| Degradation of the fluoroquinolone enrofloxacin by the brown rot fungus Gloeophyllum striatum: identification of metabolites | Q28254007 | ||
| Ring fission of anthracene by a eukaryote | Q28334040 | ||
| Isolation and structural elucidation of polar photometabolites | Q33384156 | ||
| Microbiological transformation of enrofloxacin by the fungus Mucor ramannianus. | Q33786326 | ||
| Quinolone generations: natural history or natural selection? | Q33918534 | ||
| Modification of norfloxacin by a Microbacterium sp. strain isolated from a wastewater treatment plant | Q33949396 | ||
| Comparative mutant prevention concentrations of pradofloxacin and other veterinary fluoroquinolones indicate differing potentials in preventing selection of resistance | Q34077142 | ||
| Quinolones: a comprehensive review | Q34115365 | ||
| The fluoroquinolone antibacterials: past, present and future perspectives | Q34143393 | ||
| Comparative activity of pradofloxacin against anaerobic bacteria isolated from dogs and cats | Q34688037 | ||
| Antimicrobial susceptibility of Pasteurella multocida isolated from swine and poultry | Q44510392 | ||
| Promoting resistance by the emission of antibiotics from hospitals and households into effluent | Q44574969 | ||
| A seven-year survey of susceptibility to marbofloxacin of pathogenic strains isolated from pets | Q45157542 | ||
| Outlines of an "exploding" network of metabolites generated from the fluoroquinolone enrofloxacin by the brown rot fungus Gloeophyllum striatum | Q46775248 | ||
| Patterns of metabolites produced from the fluoroquinolone enrofloxacin by basidiomycetes indigenous to agricultural sites | Q46836031 | ||
| Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 | ||
| Norfloxacin: a new drug in the treatment of falciparum malaria | Q47893594 | ||
| Pharmacokinetics, urinary excretion and plasma protein binding of danofloxacin following intravenous administration in buffalo calves (Bubalus bubalis). | Q51762264 | ||
| Sunlight-induced degradation of soil-adsorbed veterinary antimicrobials Marbofloxacin and Enrofloxacin. | Q53208302 | ||
| Tuning of antibacterial activity of a cyclopropyl fluoroquinolone by variation of the substituent at position C-8. | Q54352249 | ||
| Microbial transformations of antitumor compounds. 1. Conversion of acronycine to 9-hydroxyacronycine by Cunninghamella echinulata | Q54443771 | ||
| Antibacterial activity of the metabolites of ciprofloxacin and its significance in the bioassay. | Q54767527 | ||
| Fungal Transformation of an Antimicrobial Fluoroquinolone Drug During Growth on Poultry Litter Materials | Q58055074 | ||
| Regioselective transformation of ciprofloxacin toN-acetylciprofloxacin by the fungusMucor ramannianus | Q58055157 | ||
| Occurrence and Fate of Antibiotics as Trace Contaminants in Wastewaters, Sewage Sludges, and Surface Waters | Q60691293 | ||
| Synthesis and structure-activity relationships of 7-diazabicycloalkylquinolones, including danofloxacin, a new quinolone antibacterial agent for veterinary medicine | Q67486396 | ||
| Structure-activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids | Q71443600 | ||
| Quantitation of norfloxacin, a new antibacterial agent in human plasma and urine by ion-pair reverse-phase chromatography | Q72805292 | ||
| Experiences on the efficacy and safety of nalidixic acid, oxolinic acid, cinoxacin and norfloxacin in the treatment of urinary tract infections (UTI) | Q72834814 | ||
| Microbial models of soil metabolism: biotransformations of danofloxacin | Q74126747 | ||
| [Quinolones in the environment: biological breakdown of gyrase inhibitors] | Q74563777 | ||
| In vitro susceptibility testing and quality control parameters for sarafloxacin (A-56620): a fluoroquinolone used for treatment and control of colibacillosis in poultry. Quality Control Study Group | Q77474987 | ||
| Biotransformation of flumequine by the fungus Cunninghamella elegans | Q79379122 | ||
| Acetylation and nitrosation of ciprofloxacin by environmental strains of mycobacteria | Q80319258 | ||
| Degradation of the antibiotics norfloxacin and ciprofloxacin by a white-rot fungus and identification of degradation products | Q84971907 | ||
| Cinoxacin A Review of its Pharmacological Properties and Therapeutic Efficacy in the Treatment of Urinary Tract Infections | Q34708613 | ||
| Transformation of the antibacterial agent norfloxacin by environmental mycobacteria | Q35023629 | ||
| Mechanism of action of nalidixic acid: Purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme | Q35059616 | ||
| Fluoroquinolones: action and resistance | Q35061150 | ||
| In vitro antibacterial activity and pharmacodynamics of new quinolones | Q35104038 | ||
| Development of the quinolones | Q35110229 | ||
| Degradation of the fluoroquinolone enrofloxacin by wood-rotting fungi | Q35195043 | ||
| Moxifloxacin: a review of its use in the management of bacterial infections | Q35904814 | ||
| Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria | Q35991425 | ||
| Structural features of new quinolones and relationship to antibacterial activity against Gram-positive bacteria | Q36448769 | ||
| Fluoroquinolone antibiotics in the environment. | Q36914196 | ||
| Plasmid-mediated quinolone resistance in gram-negative bacterial species: an update | Q37411359 | ||
| The 4-quinolone-3-carboxylic acid motif as a multivalent scaffold in medicinal chemistry | Q37481859 | ||
| Acronycine derivatives: a promising series of anticancer agents | Q37548463 | ||
| Quinolones: action and resistance updated | Q37595559 | ||
| Does ciprofloxacin have an obverse and a reverse? | Q37704804 | ||
| Ciprofloxacin: review on developments in synthetic, analytical, and medicinal aspects | Q37710505 | ||
| Photodegradation of some quinolones used as antimicrobial therapeutics | Q38569950 | ||
| Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines | Q39033659 | ||
| Degradation of ciprofloxacin by basidiomycetes and identification of metabolites generated by the brown rot fungus Gloeophyllum striatum | Q39481224 | ||
| Defluorinated sparfloxacin as a new photoproduct identified by liquid chromatography coupled with UV detection and tandem mass spectrometry. | Q39558465 | ||
| Hydroxylated metabolites of 2,4-dichlorophenol imply a fenton-type reaction in Gloeophyllum striatum | Q39583401 | ||
| Environmental metabolites of fluoroquinolones: synthesis, fractionation and toxicological assessment of some biologically active metabolites of ciprofloxacin | Q39656263 | ||
| Comparative single-dose pharmacokinetics of four quinolones, oxolinic acid, flumequine, sarafloxacin, and enrofloxacin, in Atlantic salmon (Salmo salar) held in seawater at 10 degrees C. | Q39779679 | ||
| In vitro activities of 25 quinolones and fluoroquinolones against liver and blood stage Plasmodium spp | Q39792650 | ||
| Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro | Q39818643 | ||
| Distribution, fate and risk assessment of antibiotics in sewage treatment plants in Hong Kong, South China | Q39977147 | ||
| Microbiological metabolism of naphthyridines. | Q40717653 | ||
| Norfloxacin is inferior to chloroquine for falciparum malaria in northwestern Zambia: a comparative clinical trial | Q41940220 | ||
| Ciprofloxacin treatment of drug-resistant falciparum malaria | Q41941639 | ||
| Metabolite proving fungal cleavage of the aromatic core part of a fluoroquinolone antibiotic | Q42569707 | ||
| Formation of conjugates from ciprofloxacin and norfloxacin in cultures of Trichoderma viride | Q42779069 | ||
| Photochemical degradation of marbofloxacin and enrofloxacin in natural waters | Q43060360 | ||
| Occurrence and dissipation of veterinary antibiotics in two typical swine wastewater treatment systems in east China | Q43330318 | ||
| Acetylation of fluoroquinolone antimicrobial agents by an Escherichia coli strain isolated from a municipal wastewater treatment plant | Q43367661 | ||
| 1,8-NAPHTHYRIDINE DERIVATIVES. A NEW CLASS OF CHEMOTHERAPEUTIC AGENTS. | Q43498212 | ||
| The safety and efficacy of topical norfloxacin compared with chloramphenicol for the treatment of external ocular bacterial infections. The Norfloxacin-Chloramphenicol Ophthalmic Study Group | Q43522357 | ||
| Metabolism of the veterinary fluoroquinolone sarafloxacin by the fungus Mucor ramannianus | Q43649333 | ||
| The fungus Pestalotiopsis guepini as a model for biotransformation of ciprofloxacin and norfloxacin | Q43731768 | ||
| Transformation of cinoxacin by Beauveria bassiana. | Q44120442 | ||
| P433 | issue | 12 | |
| P921 | main subject | quinolones | Q426549 |
| P304 | page(s) | 1731-1740 | |
| P577 | publication date | 2012-09-25 | |
| P1433 | published in | Journal of Industrial Microbiology & Biotechnology | Q1709847 |
| P1476 | title | Microbial transformations of antimicrobial quinolones and related drugs | |
| P478 | volume | 39 |
| Q38172427 | Transformation of saturated nitrogen-containing heterocyclic compounds by microorganisms. | cites work | P2860 |
Search more.